Nava Siegelmann‐Danieli

851 total citations
57 papers, 644 citations indexed

About

Nava Siegelmann‐Danieli is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Nava Siegelmann‐Danieli has authored 57 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in Nava Siegelmann‐Danieli's work include Lung Cancer Treatments and Mutations (12 papers), Breast Cancer Treatment Studies (10 papers) and Lung Cancer Research Studies (7 papers). Nava Siegelmann‐Danieli is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), Breast Cancer Treatment Studies (10 papers) and Lung Cancer Research Studies (7 papers). Nava Siegelmann‐Danieli collaborates with scholars based in Israel, United States and Poland. Nava Siegelmann‐Danieli's co-authors include Kenneth H. Buetow, Moshe Stein, Corey J. Langer, John A. Ridge, Alexandra L. Hanlon, Ruth Padmore, Douglas A. Fein, Timothy J. Murphy, Jeffrey W. Prichard and Jacob Bar‐Ziv and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Nava Siegelmann‐Danieli

48 papers receiving 618 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nava Siegelmann‐Danieli Israel 15 277 155 151 146 96 57 644
Fernando Lara-Medina Mexico 17 487 1.8× 159 1.0× 201 1.3× 411 2.8× 41 0.4× 40 906
Marit Holmqvist Sweden 15 329 1.2× 277 1.8× 91 0.6× 293 2.0× 28 0.3× 19 766
László Thurzó Hungary 14 213 0.8× 46 0.3× 110 0.7× 228 1.6× 47 0.5× 45 613
Oscar W.K. Mang Hong Kong 11 257 0.9× 46 0.3× 50 0.3× 138 0.9× 47 0.5× 17 486
T Cooke United Kingdom 15 333 1.2× 190 1.2× 171 1.1× 270 1.8× 19 0.2× 35 894
Yuh‐Seog Jung South Korea 15 170 0.6× 66 0.4× 188 1.2× 116 0.8× 68 0.7× 48 696
Francesco Nuzzo Italy 15 710 2.6× 127 0.8× 229 1.5× 351 2.4× 19 0.2× 48 1.2k
P Murray United Kingdom 10 439 1.6× 61 0.4× 93 0.6× 130 0.9× 21 0.2× 15 682
Pilar Zamora Spain 17 303 1.1× 50 0.3× 270 1.8× 202 1.4× 14 0.1× 55 795
Laurence Digue France 16 343 1.2× 38 0.2× 151 1.0× 188 1.3× 245 2.6× 57 927

Countries citing papers authored by Nava Siegelmann‐Danieli

Since Specialization
Citations

This map shows the geographic impact of Nava Siegelmann‐Danieli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nava Siegelmann‐Danieli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nava Siegelmann‐Danieli more than expected).

Fields of papers citing papers by Nava Siegelmann‐Danieli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nava Siegelmann‐Danieli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nava Siegelmann‐Danieli. The network helps show where Nava Siegelmann‐Danieli may publish in the future.

Co-authorship network of co-authors of Nava Siegelmann‐Danieli

This figure shows the co-authorship network connecting the top 25 collaborators of Nava Siegelmann‐Danieli. A scholar is included among the top collaborators of Nava Siegelmann‐Danieli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nava Siegelmann‐Danieli. Nava Siegelmann‐Danieli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Arunachalam, Ashwini, et al.. (2024). Mapping the patient journey and treatment patterns in early-stage (stage I-III) non-small cell lung cancer. Cancer Epidemiology. 93. 102678–102678.
5.
Chodick, Gabriel, et al.. (2023). Real-world outcomes of patients with metastatic endocrine-responsive breast cancer receiving palbociclib-based combinations. Future Oncology. 19(21). 1473–1483. 1 indexed citations
6.
7.
Siegelmann‐Danieli, Nava, Victoria Neiman, Avital Bareket‐Samish, et al.. (2023). Whole exome germline sequencing in early‐onset prostate cancer patients: Genomic findings and clinical outcomes. The Prostate. 84(1). 39–46. 2 indexed citations
8.
Siegelmann‐Danieli, Nava, et al.. (2023). Association between diabetes mellitus and reduced efficacy of pembrolizumab in non–small cell lung cancer. Cancer. 129(18). 2789–2797. 10 indexed citations
9.
Siegelmann‐Danieli, Nava, et al.. (2023). Is access to adjuvant treatments prioritized over therapies for metastatic cancer? The Israeli experience.. Journal of Clinical Oncology. 41(16_suppl). e18599–e18599. 2 indexed citations
10.
Arunachalam, Ashwini, et al.. (2021). Real-World Study of PD-L1 Testing Patterns and Treatment Distribution in Patients with Metastatic Non-Small-Cell Lung Cancer in Israel. Immunotherapy. 13(10). 851–861. 3 indexed citations
11.
Bareket‐Samish, Avital, et al.. (2021). Hormone-Replacement Therapy and Its Association with Breast Cancer Subtypes: A Large Retrospective Cohort Study. International Journal of Women s Health. Volume 13. 1207–1216. 4 indexed citations
12.
Siegelmann‐Danieli, Nava, et al.. (2020). Acupuncture Treatment in Cancer Patients in a Community Setting: Feasibility and Positive Impact on Quality of Life. The Journal of Alternative and Complementary Medicine. 26(8). 758–759. 2 indexed citations
13.
Siegelmann‐Danieli, Nava, et al.. (2017). Does levonorgestrel-releasing intrauterine system increase breast cancer risk in peri-menopausal women? An HMO perspective. Breast Cancer Research and Treatment. 167(1). 257–262. 16 indexed citations
14.
Siegelmann‐Danieli, Nava, et al.. (2016). ecancermedicalscience. ecancermedicalscience. 7. 380–380. 12 indexed citations
15.
Siegelmann‐Danieli, Nava, et al.. (2016). A Novel Computational Tool for Mining Real-Life Data: Application in the Metastatic Colorectal Cancer Care Setting. PLoS ONE. 11(5). e0154689–e0154689.
16.
Samuels, Noah, et al.. (2012). In Reply. The Oncologist. 17(5). 742–743. 1 indexed citations
17.
Silverman, Barbara, Nava Siegelmann‐Danieli, Rony Braunstein, & Ehud Kokia. (2010). Trends in breast cancer incidence associated with reductions in the use of hormone replacement therapy. Cancer Epidemiology. 35(1). 11–16. 6 indexed citations
18.
Siegelmann‐Danieli, Nava, et al.. (2010). Potent CYP2D6 Inhibiting drugs do not increase relapse rate in early breast cancer patients treated with adjuvant tamoxifen. Breast Cancer Research and Treatment. 125(2). 505–510. 23 indexed citations
19.
Siegelmann‐Danieli, Nava & Kenneth H. Buetow. (1999). Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk. British Journal of Cancer. 79(3-4). 456–463. 94 indexed citations
20.
Siegelmann‐Danieli, Nava, Alexandra L. Hanlon, John A. Ridge, et al.. (1998). Oral tongue cancer in patients less than 45 years old: institutional experience and comparison with older patients.. Journal of Clinical Oncology. 16(2). 745–753. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fernando Lara-Medina Breakdown of academic impact, for papers by Marit Holmqvist Breakdown of academic impact, for papers by László Thurzó Breakdown of academic impact, for papers by Oscar W.K. Mang Breakdown of academic impact, for papers by T Cooke Breakdown of academic impact, for papers by Yuh‐Seog Jung Breakdown of academic impact, for papers by Francesco Nuzzo Breakdown of academic impact, for papers by P Murray Breakdown of academic impact, for papers by Pilar Zamora Breakdown of academic impact, for papers by Laurence Digue
Rankless by CCL
2026